Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal Polyps
NCT ID: NCT04160832
Last Updated: 2025-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2019-10-24
2024-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
NCT04624555
Genetic Study of Young Patients With Colorectal Cancer
NCT00044967
Hereditary Colorectal and Associated Tumor Registry Study
NCT00633607
Implication of Genetic Variations in Long Intergenic Non-coding RNA 00511 (LINC00511) in Colorectal Cancer
NCT06534242
Screening and Risk Factors of Colon Neoplasia
NCT01647776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multi-Cancer Cancer Panel
Eligible patients will receive genetic testing to determine germline cancer predisposition.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stated willingness to comply with all study procedures and be available for the duration of the study
* Be a male or female aged 18-89
* Undergone colonoscopy
* At least one advanced colorectal polyp, defined as having any of the following:
* Any polyp ≥ 1cm (adenoma or serrated polyp)
* Any polyp with villous architecture
* Any polyp with high-grade dysplasia
* Sessile serrated polyps with any dysplasia
* Traditional serrated adenoma
Exclusion Criteria
* Personal history of inflammatory bowel disease
* Personal history of colorectal cancer
* Polyp histology or size unavailable or not documented
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Swati Patel, MD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Denver
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-2827.cc
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.